Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study

Open Access

Peer-reviewed

Research Article

Kasper Søltoft Larsen ,

* E-mail: kaslarsen@health.sdu.dk

Affiliations Clinical Pharmacology, Department of Public Health, University of Southern Denmark, JB Winsloewvej 19.2, DK-5000, Odense C, Denmark, Department of Rheumatology, Odense University Hospital, Sdr. Boulevard 29, DK-5000, Odense C, Denmark
⨯
Anton Pottegård,

Affiliation Clinical Pharmacology, Department of Public Health, University of Southern Denmark, JB Winsloewvej 19.2, DK-5000, Odense C, Denmark
⨯
Hanne M. Lindegaard,

Affiliation Department of Rheumatology, Odense University Hospital, Sdr. Boulevard 29, DK-5000, Odense C, Denmark
⨯
Jesper Hallas

Affiliations Clinical Pharmacology, Department of Public Health, University of Southern Denmark, JB Winsloewvej 19.2, DK-5000, Odense C, Denmark, Department of Clinical Chemistry & Pharmacology, Odense University Hospital, JB Winsloewvej 19.2, DK-5000, Odense C, Denmark
⨯

Reader Comments (0)

Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Cardiovascular therapy
Is the Subject Area "Cardiovascular therapy" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Gout
Is the Subject Area "Gout" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Cardiovascular diseases
Is the Subject Area "Cardiovascular diseases" applicable to this article?

Thanks for your feedback.
Case-control studies
Is the Subject Area "Case-control studies" applicable to this article?

Thanks for your feedback.
Denmark
Is the Subject Area "Denmark" applicable to this article?

Thanks for your feedback.